Dr Modesitt on Shared Decision-Making When Choosing PARP Inhibitors in Ovarian Cancer

Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer.

Related Keywords

Susanc Modesitt , ,Division Of Gynecologic Oncology ,Emory University School Of Medicine ,Department Of Gynecology ,Gynecologic Oncology ,Emory University School ,